Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Reproductive Biology and Endocrinology
Published in: Reproductive Biology and Endocrinology 1/2017

Open Access 01-12-2017 | Research

Evolution of metabolic alterations 5 Years after early puberty in a cohort of girls predisposed to polycystic ovary syndrome

Authors: Soren Harnois-Leblanc, Andréanne Trottier, Samuel Leblanc, Marie-Claude Battista, David H. Geller, Jean-Patrice Baillargeon

Published in: Reproductive Biology and Endocrinology | Issue 1/2017

Login to get access

Abstract

Background

We and others have observed that young girls predisposed to polycystic ovary syndrome (PCOS) display defective insulin sensitivity, beta-cell function and non-esterified fatty acids (NEFA) suppressibility during early pubertal years, compared to controls. Our objective is to assess whether these differences in glucose and NEFA metabolisms persist after 5 years in late/post-puberty.

Methods

We conducted a prospective cohort study between 2007 and 2015 with 4–6 years of follow-up in an academic institution research center. We compared 8 daughters and sisters of PCOS women (PCOSr) to 8 age-matched girls unrelated to PCOS (±1.5 years). Girls were assessed initially at 8–14 years old and re-assessed after a median follow-up of 5.4 years, at 13–21 years old. Our main measures were a frequently sampled intravenous glucose tolerance test (FSivGTT)-derived insulin sensitivity (IS) and beta-cell function (disposition index, DIFSivGTT); and indices of NEFA suppression during FSivGTT (logn-linear slope of NEFA and T50 of NEFA suppression).

Results

At follow-up, both PCOSr and controls had similar results: IS = 3.2 vs 3.4 (p = 0.88), DIFSivGTT = 1926 vs 1380 (p = 0.44), logn-linear slope = −0.032 vs −0.032 (p = 0.88) and T50NEFA = 18.1 vs 20.8 min (p = 0.57). IS, DIFSivGTT and NEFA suppressibility were stable in PCOSr after 5 years, but decreased significantly in controls (all p < 0.05).

Conclusions

Impaired metabolism observed during early puberty in girls predisposed to PCOS remains stable after 5 years whereas control girls deteriorated their metabolic parameters. Therefore, both groups become comparable in late/post-puberty. Early puberty may thus represent a window during which metabolic alterations are transiently apparent in girls at risk of PCOS.
Literature
1.
Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. Endocrine Society. 2004 Jun;89(6):2745–9.
2.
March WA, Moore VM, Willson KJ, Phillips DIW, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. Oxford University Press. 2010 Feb;25(2):544–51.
3.
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale H, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. American Society for Reproductive Medicine. 2009 Feb 1;91(2):456–88.
4.
Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv. 2004 Feb;59(2):141–54.CrossRefPubMed
5.
Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. Endocrine Society. 1999 Jan;84(1):165–9.
6.
Kahsar-Miller MD, Nixon C, Boots LR, Go RC, Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril. 2001 Jan;75(1):53–8.CrossRefPubMed
7.
Yildiz BO, Yarali H, Oguz H, Bayraktar M. Glucose intolerance, insulin resistance, and Hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003 May;88(5):2031–6.CrossRefPubMed
8.
Ünlühızarcı K, Özocak M, Tanrıverdi F, Atmaca H, Keleştimur F. Investigation of hypothalamo-pituitary-gonadal axis and glucose intolerance among the first-degree female relatives of women with polycystic ovary syndrome. Fertil Steril. 2007 Jun;87(6):1377–82.CrossRefPubMed
9.
Sir-Petermann T, Angel B, Maliqueo M, Carvajal F, Santos JL, Pérez-Bravo F. Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome. Diabetologia. Springer-Verlag. 2002 Jul;45(7):959–64.
10.
Baillargeon JP, Carpentier AC. Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects. Diabetologia. 2007 Sep 27;50(12):2424–32.CrossRefPubMed
11.
Sir-Petermann T, Maliqueo M, Codner E, Echiburú B, Crisosto N, Pérez V, et al. Early metabolic derangements in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007 Dec;92(12):4637–42.CrossRefPubMed
12.
Sir-Petermann T, Codner E, Pérez V, Echiburú B, Maliqueo M, Ladrón de Guevara A, et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009 Jun;94(6):1923–30.CrossRefPubMedPubMedCentral
13.
Raissouni N, Kolesnikov A, Purushothaman R, Sinha S, Bhandari S, Bhangoo A, et al. Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome. Int J Pediatr Endocrinol. BioMed Central Ltd. 2012;2012(1):14.CrossRefPubMedPubMedCentral
14.
Torchen LC, Fogel NR, Brickman WJ, Paparodis R, Dunaif A. Persistent apparent pancreatic β-cell defects in Premenarchal PCOS relatives. J Clin Endocrinol Metab. 2014 Oct;99(10):3855–62.CrossRefPubMedPubMedCentral
15.
Trottier A, Battista M-C, Geller DH, Moreau B, Carpentier AC, Simoneau-Roy J, et al. Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome. Fertil Steril. Elsevier Inc. 2012 Dec 20;98(6):1627–34.
16.
Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res. 2006 Dec;60(6):759–63.CrossRefPubMed
17.
Sharpe RM, Franks S. Environment, lifestyle and infertility--an inter-generational issue. Nat Cell Biol 2002 Oct;4 Suppl:s33–s40.
18.
Carpentier AC. Postprandial fatty acid metabolism in the development of lipotoxicity and type 2 diabetes. Diabetes Metab. 2008 Apr;34(2):97–107.CrossRefPubMed
19.
Mai K, Bobbert T, Reinecke F, Andres J, Maser-Gluth C, Wudy SA, et al. Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial. J Clin Endocrinol Metab. Endocrine Society. 2008 Oct;93(10):3900–6.
20.
Bellanger S, Battista M-C, Fink GD, Baillargeon J-P. Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells. Steroids. 2012 Mar 10;77(4):347–53.CrossRefPubMed
21.
Pesant M-H, Desmarais G, Fink GD, Baillargeon J-P. Reference ranges for total and calculated free and bioavailable testosterone in a young healthy women population with normal menstrual cycles or using oral contraception. Clin Biochem. 2012 Jan;45(1–2):148–50.CrossRefPubMed
22.
Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child BMJ Group. 1969 Jun;44(235):291–303.CrossRef
23.
Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. The Endocrine Society. 1961 Nov;21(11):1440–7.
24.
25.
26.
Després J-P, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. Lippincott Williams & Wilkins. 2008 Jun;28(6):1039–49.
27.
Sharma AK, Metzger DL, Daymont C, Hadjiyannakis S, Rodd CJ. LMS tables for waist-circumference and waist-height ratio Z-scores in children aged 5–19 y in NHANES III: association with cardio-metabolic risks. Pediatr Res. 2015 Sep 2;78(6):723–9.CrossRefPubMed
28.
Henderson M, Rabasa-Lhoret R, Bastard JP, Chiasson JL, Baillargeon JP, Hanley JA, et al. Measuring insulin sensitivity in youth: How do the different indices compare with the gold-standard method? Diab Metab. Elsevier Masson SAS. 2011 Feb 1;37(1):72–8.
29.
Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999 Sep;22(9):1462–70.CrossRefPubMed
30.
Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol. 2000 Jan 15;151(2):190–8.CrossRefPubMed
31.
Buchanan TA, Xiang AH, Peters RK, Kjos SL, Berkowitz K, Marroquin A, et al. Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes. 2000 May;49(5):782–8.CrossRefPubMed
32.
Carpentier A, Patterson BW, Leung N, Lewis GF. Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans. Diabetes. 2002 Jun;51(6):1867–75.CrossRefPubMed
33.
Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther. Mary Ann Liebert, Inc. 2003;5(6):1003–15.CrossRefPubMed
34.
Marcelli-Tourvieille S, Hubert T, Pattou F, Vantyghem MC. Acute insulin response (AIR): review of protocols and clinical interest in islet transplantation. Diabetes Metab. 2006 Sep;32(4):295–303.CrossRefPubMed
35.
Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia. 2003 Jan;46(1):3–19.CrossRefPubMed
36.
Maliqueo M, Galgani JE, Pérez-Bravo F, Echiburú B, de Guevara AL, Crisosto N, et al. Relationship of serum adipocyte-derived proteins with insulin sensitivity and reproductive features in pre-pubertal and pubertal daughters of polycystic ovary syndrome women. Eur J Obstet Gynecol Reprod Biol. 2012 Mar;161(1):56–61.CrossRefPubMed
37.
Kent SC, Gnatuk CL, Kunselman AR, Demers LM, Lee PA, Legro RS. Hyperandrogenism and Hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab. 2008 May;93(5):1662–9.CrossRefPubMedPubMedCentral
38.
Amato MC, Vesco R, Vigneri E, Ciresi A, Giordano C. Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance. J Endocrinol Invest Springer International Publishing. 2015 Dec;38(12):1319–26.
39.
Cardoso RC, Veiga-Lopez A, Moeller J, Beckett E, Pease A, Keller E, et al. Developmental programming: impact of gestational steroid and metabolic milieus on adiposity and insulin sensitivity in prenatal testosterone-treated female sheep. Endocrinology. 2016 Feb;157(2):522–35.CrossRefPubMed
Metadata
Title
Evolution of metabolic alterations 5 Years after early puberty in a cohort of girls predisposed to polycystic ovary syndrome
Authors
Soren Harnois-Leblanc
Andréanne Trottier
Samuel Leblanc
Marie-Claude Battista
David H. Geller
Jean-Patrice Baillargeon
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2017
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/s12958-017-0275-0

Other articles of this Issue 1/2017

Reproductive Biology and Endocrinology 1/2017 Go to the issue

Research

Natriuretic peptides improve the developmental competence of in vitro cultured porcine oocytes

Research

Proteomic analysis of human follicular fluid associated with successful in vitro fertilization

Research

Hexokinase 2 drives glycogen accumulation in equine endometrium at day 12 of diestrus and pregnancy

Research

The impact of endometriosis on the outcome of Assisted Reproductive Technology

Research

Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions

Research

REAC technology as optimizer of stallion spermatozoa liquid storage